Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Other Non Operating Income (2019 - 2020)

Pliant Therapeutics has reported Other Non Operating Income over the past 2 years, most recently at -$97000.0 for Q4 2020.

  • Quarterly Other Non Operating Income rose 42.26% to -$97000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$346000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at -$1.8 million for FY2025, N/A changed from the prior year.
  • Other Non Operating Income was -$97000.0 for Q4 2020 at Pliant Therapeutics, down from $55000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $55000.0 in Q3 2020 and troughed at -$168000.0 in Q4 2019.